Literature DB >> 6127223

The alpha 1- and alpha 2-adrenoceptor involvement in the central cardiovascular action of clonidine in the conscious renal hypertensive cat.

P J Beckett, L Finch.   

Abstract

An attempt has been made to characterise the alpha-adrenoceptor subtype (alpha 1 or alpha 2) mediating the hypotensive and bradycardic action of clonidine in conscious renal hypertensive cats. The relatively selective alpha 2-adrenoceptor agonists clonidine, UK-14,304, guanfacine and lofexidine caused significant hypotension and bradycardia when given intracerebroventricularly (i.c.v.). This suggests that alpha 2-adrenoceptors can mediate hypotension and bradycardia. However, both alpha 1- and alpha 2-adrenoceptor antagonists, prazosin, UK-33,274, corynanthine, yohimbine, rauwolscine and RS21361 blocked the hypotensive effect of clonidine. These results suggest an alpha 1-adrenoceptor may also mediate the central hypotensive action of clonidine, or possibly that the central alpha-adrenoceptors in which clonidine acts, may show pharmacological differences to peripheral alpha 1- and alpha 2-subtypes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127223     DOI: 10.1016/0014-2999(82)90504-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Cardiovascular responses to static exercise in conscious cats: effects of intracerebroventricular injection of clonidine.

Authors:  A Ally; G A Hand; J H Mitchell
Journal:  J Physiol       Date:  1996-03-01       Impact factor: 5.182

Review 2.  The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.

Authors:  P Ernsberger; J E Friedman; R J Koletsky
Journal:  J Hypertens Suppl       Date:  1997-01

3.  Prazosin partly blocks clonidine-induced hypotension in patients with essential hypertension.

Authors:  J Kapocsi; C Farsang; E S Vizi
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Changes in central serotoninergic transmission affect clonidine analgesia in monkeys.

Authors:  M T Lin; J M Lee; J T Cheng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

5.  Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.

Authors:  J H Krystal; C J McDougle; S W Woods; L H Price; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.

Authors:  J T Coull; B J Sahakian; J R Hodges
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

7.  Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.

Authors:  P Lund-Johansen; P Omvik; H Haugland
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.